MONOCLONAL ANTIBODY

Similar documents
Anti-dimethyl Histone H3 (Lys9)

Microsoft Word - CAC-CE037A_ver.2.doc

Microsoft Word - CAC-CE031A_ver.2

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

Huawei G6-L22 QSG-V100R001_02

J No J. J


{.w._.p7_.....\.. (Page 6)


No.3 14

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,

1..FEM FEM 3. 4.



Introduction ur company has just started service to cut out sugar chains from protein and supply them to users by utilizing the handling technology of

/‚“1/ŒxŒ{‚×›î’æ’¶


Jpn.J.Leprosy 67, (1998)

Kyushu Communication Studies 第2号

< F909D96EC2091E633358D862E696E6462>


研究成果報告書(基金分)

25 D Effects of viewpoints of head mounted wearable 3D display on human task performance

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

Core Ethics Vol.

FA

研究成果報告書

CHEMOTHERAPY APR. 1984


How to read the marks and remarks used in this parts book. Section 1 : Explanation of Code Use In MRK Column OO : Interchangeable between the new part

(43) Vol.33, No.6(1977) T-239 MUTUAL DIFFUSION AND CHANGE OF THE FINE STRUCTURE OF WET SPUN ANTI-PILLING ACRYLIC FIBER DURING COAGULATION, DRAWING AND

How to read the marks and remarks used in this parts book. Section 1 : Explanation of Code Use In MRK Column OO : Interchangeable between the new part


How to read the marks and remarks used in this parts book. Section 1 : Explanation of Code Use In MRK Column OO : Interchangeable between the new part

基本操作ガイド

NotePC 8 10cd=m 2 965cd=m Note-PC Weber L,M,S { i {

2


How to read the marks and remarks used in this parts book. Section 1 : Explanation of Code Use In MRK Column OO : Interchangeable between the new part


( ) ( ) 87 ( ) 3 ( 150mg/l) cm cm 50cm a 2.0kg 2.0kg

untitled



WARNING To reduce the risk of fire or electric shock,do not expose this apparatus to rain or moisture. To avoid electrical shock, do not open the cabi

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

untitled


基本操作ガイド


_07.indd

操作ガイド(本体操作編)

企業内システムにおけるA j a x 技術の利用

) ,

〈論文〉中部圏構想の断章と高速自動車道の建設


エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I



VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity



/toushin/.htm GP GP GP GP GP p.

Time Variation of Earthquake Volume and Energy-Density with Special Reference to Tohnankai and Mikawa Earthquake Akira IKAMi and Kumizi IIDA Departmen

「フェリー等によるタンク自動車等の輸送に係る調査」における

操作ガイド(本体操作編)

„h‹¤.05.07

先端社会研究 ★5★号/4.山崎

Kyoto University * Filipino Students in Japan and International Relations in the 1930s: An Aspect of Soft Power Policies in Imperial Japan

Table 2 Cases of Nail Deformity Associated with upward Distortion of Distal Soft Tissue No. Age Sex Affected RegionsDuration Results M Both grea

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書

Bull. of Nippon Sport Sci. Univ. 47 (1) Devising musical expression in teaching methods for elementary music An attempt at shared teaching

ユーザーズマニュアル

橡自動車~1.PDF


明治期の新聞における「鶏姦」報道の特徴 : 『読売新聞』と『朝日新聞』の分析から

On the Wireless Beam of Short Electric Waves. (VII) (A New Electric Wave Projector.) By S. UDA, Member (Tohoku Imperial University.) Abstract. A new e

2 146

.,,,.,,,,,.,,,, Inoue,.,,,,.,.,,.,,,.,.,,,.,,,,,.,,.,,.,,,.,,,,

Adult Attachment Projective AAP PARS PARS PARS PARS Table

「プログラミング言語」 SICP 第4章 ~超言語的抽象~ その6

How to read the marks and remarks used in this parts book. Section 1 : Explanation of Code Use In MRK Column OO : Interchangeable between the new part

西川町広報誌NETWORKにしかわ2011年1月号

<95DB8C9288E397C389C88A E696E6462>

ñ{ï 01-65

202


116,/ / - /-, /1 /2 0 / ,, / 3 ing / , 2, 3, , 3,,. ISO. /.. 0 -,. ISO., 0-

(a) Speech index Res, (b) Respiration index Fig.l Feature index of alternate speech

speax45CL/CLW

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U

大学論集第42号本文.indb


社会技術論文集

The Phase Behavior of Monooleoylglycerol-Water Systems Mivoshi Oil & Fat Co.. Ltd. Faculty of Science and Technology, Science University of Tokyo Inst

43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* *,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * ,* , 0.. /3 : +/,.

FC741E2_091201


日本看護管理学会誌15-2

Corrections of the Results of Airborne Monitoring Surveys by MEXT and Ibaraki Prefecture

Transcription:

MONOCLONAL ANTIBODY For research use only. Not for clinical diagnosis. Catalog No. MCA-MABI0323-100-EX Anti-Histone H3 (Lys27), mouse monoclonal antibody Product type Host Source Primary antibodies Culture supernatant of serum free medium Form Liquid PBS+0.05% sodium azaid Volume Concentration 100 ul 1 mg/ml Antigen 19 amino acid residues around Lys27 of human Histone H3.1 Clone MABI0323 Isotype IgG1 Application notes Recommended use Immunoprecipitation, Immunostaining, Immunoblot Recommended dilutions *Immunoprecipitation 1-5 ug/5 ul Sepharose Immunostaining 0.5-1 ug/ml Immunoblot 0.5-1 ug/ml * IgG has weak combination with protein A and protein G. Please use the beads which connect anti-mouse IgG antibodies such as anti-mouse IgG sepharose for immunoprecipitation. Storage References Optimal dilutions/concentrations should be determined by the end user. Store below -20 C. Aliquot to avoid cycles of freeze/thaw. Kimura H, Hayashi-Takanaka Y, Goto Y, Takizawa N, Nozaki N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct Funct. 2008;33(1):61-73. www.cosmobio.co.jp

Anti-Histone H3 (Lys27), mouse monoclonal antibody For research use only. Not for clinical diagnosis. Manufactured by MAB Institute, Inc. TOYO 2CHOME, KOTO-KU, TOKYO, 135-0016, JAPAN URL: http://www.cosmobio.co.jp e-mail: export@cosmobio.co.jp [Outside Japan] Phone : +81-3-5632-9617 [ 国内連絡先 ] Phone : +81-3-5632-9610 FAX : +81-3-5632-9618 FAX : +81-3-5632-9619

World's First!!! Histone Variant Monoclonal Antibodies Anti Histone H3.1/H3.2 [Clone: 6G3C7] Anti Histone H3.3 [Clone: 6C4A3] Anti Histone H3.1/H3.2 [Clone: 1D4F2] Anti Histone H3.3 [Clone: 1E4A3] Nucleosomes are composed of four different histone proteins designated H2A, H2B, H3, and H4. In humans, five variants of histone H3 are reported: H3.1, H3.2, H3.3, H3t, and CENP-A. The two major Histone H3 variants, H3.1 and H3.3, are the main variants displaying distinct genomic localization patterns in eukaryotes. Deposition of Histone H3.1 is associated with DNA synthesis during DNA replication and possibly DNA repair, while Histone H3.3 is incorporated independently of DNA synthesis and is the predominant form of H3 found in non-dividing cells. Hence, these new Histone H3 variant monoclonal antibodies offer great utility for dissecting the functional significance of these H3 variants and the molecular mechanisms associated with their deposition. Recently, it was shown that a genomic gene cluster regulating skeletal myogenesis is marked by H3.3 protein prior to cellular muscle formation and that H3.3 marking of this region enables myogenic gene activation (Ref. 2). These results suggest that monitoring H3.3 marking at specific loci may be useful in the prediction of cell fate. These H3.3 monoclonal antibodies are expected to be useful probes in the field of regenerative medicine. Antibody specificity by competition peptide ELISA Fluorescence immunostaining 0 0 1.000 0.900 0.800 (1D4F2) NIH3T3 Hoechst 0 0 (1E4A3) Hoechst 79 KTDLRFQSSAVMALQEASEA 97 79 KTDLRFQSAA IGALQEASEA 97 21 ATKAARKSAPATGGVKKPH 39 21 ATKAARKSAPSTGGVKKPH 39 HeLa Experimental example These H3 variant antibodies were essential tools in a first of kind study showing that differentiation specific genes are marked for lineage specific expression by the deposition of Histone H3.3 at the onset of differentiation signaling (Ref. 2). H3.3 gene marking in skeletal muscle differentiation MARKING Chd2/MyoD-dependent H3.3 deposition Chd2 MyoD Chd2 H3.3 MyoD Myogenesis Reference 1) Hake and Allis, (2006) PNAS, 103, 6428-6435. 2) Harada et. al., (2012) EMBO J. 36, 2994-3007. Non-MARKING Chd2 MyoD H3.3 Chd2 knockdown prevents H3.3 deposition Myogenesis Description Clone Isotype Epitope Application Cat. No. Quantity Anti Histone H3.1/H3.2 6G3C7 Rat-IgG1, λ H3.1/H3.2 (79-94) IP/ WB CAC-CE-039A 100 µl 100 µg) Anti Histone H3.1/H3.2 1D4F2 IgG2b, λ H3.1/H3.2 (21-39) ChIP/ IP/ WB/ IC CAC-CE-039B 50 µl 50 µg) Anti Histone H3.3 6C4A3 Rat-IgG2a, κ H3.3 (79-97) IP/ WB CAC-CE-040A 100 µl 100 µg) Anti Histone H3.3 1E4A3 Rat-IgG2a, λ H3.3 (21-39) ChIP/ IP/ WB/ IC CAC-CE-040B 50 µl 50 µg)

ChIP. Immunostain. WB. Monoclonal Antibodies to Histone Modifications Histones are the main protein components of chromatin. To facilitate nuclear packaging and control of gene expression, DNA in chromatin is wound around nucleosome particles composed primarily of the Histones H2A, H2B, H3, and H4. Histone N-terminal regions (histone tails) protrude from the nucleosome core and are subject to a variety of reversible, regulated modifications (including acetlylation, rylation, and methylation) influencing transcription and chromatin structure. How such modifications are regulated and how these modifications effect gene expression continues to be an area of intense interest and research. In such studies, chromatin immunoprecipitation (ChIP) is perhaps the most widely used experimental procedure. Due to the inherent variability and limited supply of polyclonal antibodies, well characterized monoclonal antibodies are preferred reagents for ChIP. The versitile set of anti-histone monoclonal antibodies offered here are therefore highly valuable reagents to your lab's epigenetic toolbox. Histone H3 N-terminal modifications Histone H3 Ser10 immunostaining DAPI Anti- H3S10 Cat. No. MABI0312 DAPI/ H3S10 ART K 4 QTAR K 9 S 10 T 11 GGKAPRKQLATKAARK 27 SAPA T 32 GGVK 36 KPHR Description Host Residue Modification Clone Application Cat. No. Quantity Anti Histone H3 unmodified MABI0301 ChIP/ WB/ IC MCA-MABI0001-100-EX 100 µl 100 µg) Anti Monomethyl Histone H3 (Lys4) MABI0302 ChIP/ WB/ IC MCA-MABI0002-100-EX 100 µl 100 µg) K4 Anti Dimethyl Histone H3 (Lys4) MABI0303 ChIP/ WB/ IC MCA-MABI0003-100-EX 100 µl 100 µg) (Lysine 4) Anti Trimethyl Histone H3 (Lys4) MABI0304 ChIP/ WB/ IC MCA-MABI0004-100-EX 100 µl 100 µg) Anti Histone H3 K9Ac Rat 2G1F9 ChIP/ WB/ IC/ IHC CAC-CE-037A 100 µl 100 µg) Anti Acethyl Histone H3 (Lys9) MABI0305 ChIP/ WB/ IC MCA-MABI0005-100-EX 100 µl 100 µg) Anti Monomethyl Histone H3 (Lys9) K9 MABI0306 ChIP/ WB/ IC MCA-MABI0006-100-EX 100 µl 100 µg) Anti Dimethyl Histone H3 (Lys9) (Lysine 9) MABI0307 ChIP/ WB/ IC MCA-MABI0007-100-EX 100 µl 100 µg) Anti Trimethyl Histone H3 (Lys9) MABI0308 ChIP/ WB/ IC MCA-MABI0008-100-EX 100 µl 100 µg) Anti Acetyl Histone H3 (Lys9/27) K9/27 (Lysine 27) MABI0310 ChIP/ WB/ IC MCA-MABI0010-100-EX 100 µl 100 µg) Anti Acetyl Histone H3 (Lys27) MABI0309 ChIP/ WB/ IC MCA-MABI0009-100-EX 100 µl 100 µg) Anti Monomethyl Histone H3 (Lys27) K27 MABI0321 ChIP/ WB/ IC MCA-MABI0321-100-EX 100 µl 100 µg) coming soon! Anti Dimethyl Histone H3 (Lys27) (Lysine 27) MABI0322 ChIP/ WB/ IC MCA-MABI0322-100-EX 100 µl 100 µg) Anti Trimethyl Histone H3 (Lys27) MABI0323 ChIP/ WB/ IC MCA-MABI0323-100-EX 100 µl 100 µg) Anti Monomethyl Histone H3 (Lys36) MABI0331 ChIP/ WB/ IC MCA-MABI0331-100-EX 100 µl 100 µg) Anti Dimethyl Histone H3 (Lys36) K36 MABI0332 ChIP/ WB/ IC MCA-MABI0332-100-EX 100 µl 100 µg) Anti Trimethyl Histone H3 (Lys36) (Lysine 36) MABI0333 ChIP/ WB/ IC MCA-MABI0333-100-EX 100 µl 100 µg) Anti Histone H3 S10ph Rat S10 6G8B7 WB/ IC CAC-CE-034A 100 µl 100 µg) Anti Histone H3 (Ser10) (Serine 10) MABI0312 ChIP/ WB/ IC MCA-MABI0012-100-EX 100 µl 100 µg) Anti Histone H3 T11ph Rat T11 (Threonine 11) 6G12C5 WB/ IC CAC-CE-035A 100 µl 100 µg) Anti Histone H3 T32ph Rat T32 (Threonine 32) 6C7G12 WB/ IC CAC-CE-036A 100 µl 100 µg) Anti Histone H2B (Ser14) S14 (Serine 14) MABI0251 ChIP/ WB/ IC MCA-MABI0251-100-EX 100 µl 100 µg) Reference 1) Strahl and Allis, (2000) Nature 403, 41-45. 2) Shimada et. al., (2008) Cell 132, 221 232. 3) Kimura H, et. al., (2008) Cell Struct Funct., 33, 61 4) Ohhata T, et. al., (2008) Development., 135, 227 5) Luco RF, et. al., (2010) Science., 327, 996 (2010) 6) Rechtsteiner A, et. al., (2010) PLoS Genet., 6, e1001091 7) Furuhashi H, et. al., (2010) Epigenetics Chromatin., 3, 15 8) Matsui T, et. al., (2010) Nature., 464, 927 For research use only. Not for diagnostic use. www.cosmobio.com 10086

!! Anti Histone H3.1/H3.2 [Clone: 6G3C7] Anti Histone H3.3 [Clone: 6C4A3] Anti Histone H3.1/H3.2 [Clone: 1D4F2] Anti Histone H3.3 [Clone: 1E4A3] 0 0 0 0 1.000 0.900 0.800 79 KTDLRFQSSAVMALQEASEA 97 79 KTDLRFQSAA IGALQEASEA 97 21 ATKAARKSAPATGGVKKPH 39 21 ATKAARKSAPSTGGVKKPH 39 Rat-IgG1, λ IgG2b, λ Rat-IgG2a, κ Rat-IgG2a, λ

Histone H3 N-terminal modifications ART K 4 QTAR K 9 S 10 T 11 GGKAPRKQLATKAARK 27 SAPA T 32 GGVK 36 KPHR (Lysine 4) (Lysine 9) Lysine Lysine (Threonine 11) (Threonine 32) (Serine 14)